Viatris Inc (VTRS) stock
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/303% below fair value
$19.63−0.25 (-1.26%)
Close on Nov 20, 2026Market cap $22.55BP/E –Yield 2.45%
Viatris gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Viatris's gross profit for the twelve months ending Jun 30, 2026 was $5.13B, down 0.7% year over year. For fiscal 2025 it was $5.01B, down 10.8% from the year before. The highest annual figure on record is $6.50B in fiscal 2022.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.01B | -10.8% |
| FY2024 | Dec 31, 2024 | $5.62B | -12.7% |
| FY2023 | Dec 31, 2023 | $6.44B | -0.9% |
| FY2022 | Dec 31, 2022 | $6.50B | +16.5% |
| FY2021 | Dec 31, 2021 | $5.58B | +46.9% |
| FY2020 | Dec 31, 2020 | $3.80B | -2.6% |
| FY2019 | Dec 31, 2019 | $3.90B | -2.6% |
| FY2018 | Dec 31, 2018 | $4.00B | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.46B | +9.3% |
| Q1 FY2026 | Mar 31, 2026 | $1.16B | -0.3% |
| Q4 FY2025 | Dec 31, 2025 | $1.15B | -5.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.37B | -6.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.33B | -7.8% |
| Q1 FY2025 | Mar 31, 2025 | $1.16B | -22.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.22B | -23.9% |
| Q3 FY2024 | Sep 30, 2024 | $1.46B | -13.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.45B | -10.1% |
| Q1 FY2024 | Mar 31, 2024 | $1.50B | -2.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.60B | +25.3% |
| Q3 FY2023 | Sep 30, 2023 | $1.69B | -3.3% |
| Q2 FY2023 | Jun 30, 2023 | $1.61B | -5.6% |
| Q1 FY2023 | Mar 31, 2023 | $1.54B | -12.9% |
| Q4 FY2022 | Dec 31, 2022 | $1.27B | -17.6% |
| Q3 FY2022 | Sep 30, 2022 | $1.75B | +11.1% |
| Q2 FY2022 | Jun 30, 2022 | $1.70B | +28.3% |
| Q1 FY2022 | Mar 31, 2022 | $1.77B | +57.1% |
| Q4 FY2021 | Dec 31, 2021 | $1.55B | +118.9% |
| Q3 FY2021 | Sep 30, 2021 | $1.57B | +35.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.33B | +29.4% |
| Q1 FY2021 | Mar 31, 2021 | $1.13B | +24.4% |
| Q4 FY2020 | Dec 31, 2020 | $706.40M | – |
| Q3 FY2020 | Sep 30, 2020 | $1.16B | – |
| Q2 FY2020 | Jun 30, 2020 | $1.03B | – |
| Q1 FY2020 | Mar 31, 2020 | $906.10M | – |
See a number that looks wrong?